Anna Woloszynska-Read

5PUBLICATIONS
7CO-AUTHORS
Molecular targetsMetabolic medicineCancer cell biologyExercise physiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 02, 2025
STAG2 expression imparts distinct therapeutic vulnerabilities in muscle-invasive bladder cancer cells.

Sarah R Athans, Henry Withers, Aimee Stablewski

|Apr 02, 2024
Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer.

Swathi Ramakrishnan, Eduardo Cortes-Gomez, Sarah R Athans

|Sep 04, 2023
Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions.

Bhavisha Doshi, Sarah R Athans, Anna Woloszynska

|May 12, 2019
Association among plasma 1,25(OH)2 D, ratio of 1,25(OH)2 D to 25(OH)D, and prostate cancer aggressiveness.

Swathi Ramakrishnan, Susan E Steck, Lenore Arab

|Apr 12, 2019
Vitamin D3 enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk.

Brittany L Bunch, Yingyu Ma, Kristopher Attwood

Pageof 1

Frequent Collaborators

1 joint publications

James L Mohler

1 joint publications

Sarah R Athans

1 joint publications

Henry Withers

1 joint publications

Katerina Gurova